Tvardi Therapeutics, Inc. (TVRD)
NASDAQ: TVRD · Real-Time Price · USD
33.00
+0.16 (0.49%)
Sep 11, 2025, 10:50 AM - Market open
Tvardi Therapeutics Employees
Tvardi Therapeutics had 12 employees as of December 31, 2024.
Employees
12
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,969,333
Market Cap
309.46M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
TVRD News
- 21 days ago - Tvardi Therapeutics to Participate in the Cantor Global Healthcare Conference - Business Wire
- 27 days ago - Tvardi Therapeutics Announces Second Quarter 2025 Results and Provides Business Update - Business Wire
- 2 months ago - Tvardi Therapeutics to Participate in the BTIG Virtual Biotechnology Conference - Business Wire
- 3 months ago - Recently Listed Tvardi Therapeutics' Lead Drug 'Positioned To Drive Broad Improvement', Analyst Sees Over 150% Stock Upside - Benzinga
- 3 months ago - Tvardi Therapeutics Announces Completion of Enrollment in Phase 2 Clinical Trial of TTI-101 in Idiopathic Pulmonary Fibrosis - Business Wire
- 4 months ago - Tvardi Therapeutics to Participate in Upcoming Investor Conferences - Business Wire
- 4 months ago - Tvardi Therapeutics Announces First Quarter 2025 Results and Provides Business Update - Business Wire
- 4 months ago - Tvardi Therapeutics Announces Presentation at the American Thoracic Society 2025 Annual Conference - Business Wire